Governor Signs Emergency Law to Restore HIV Medication Access for Over 12,000 Floridians
Governor Restores In a decisive move to address a critical public health disruption, Governor Ron DeSantis has signed emergency bipartisan legislation aimed at restoring access to essential HIV medications for more than 12,000 Floridians. These individuals had recently lost coverage following abrupt changes to the state’s AIDS Drug Assistance Program (ADAP), administered by the Florida Department of Health.
The newly enacted legislation provides immediate relief through $30.9 million in emergency “bridge funding,” ensuring continuity of care for affected patients through June 30, 2026. In addition to restoring funding, the law reinstates ADAP eligibility criteria to 400 percent of the Federal Poverty Level (FPL), reversing the Department of Health’s earlier reduction to 130 percent—an action that had significantly restricted access to the program.
The bill passed unanimously in both chambers of the Florida Legislature, underscoring strong bipartisan recognition of the urgency and severity of the situation. Alongside funding and eligibility restoration, the legislation introduces new financial oversight measures, requiring the Department of Health to submit detailed monthly reports to state leadership.
Background: Sudden Policy Changes Spark Crisis
The crisis began on March 1, when the Florida Department of Health implemented sweeping changes to ADAP. These included lowering income eligibility thresholds from 400 percent to 130 percent of the Federal Poverty Level, eliminating assistance for health insurance premiums, and removing several medications from the program’s formulary. Among the most notable removals was Biktarvy, widely recognized as one of the most commonly prescribed and effective HIV treatments in the United States.
These changes left thousands of individuals uncertain about their ability to continue treatment. For people living with HIV, uninterrupted access to medication is essential—not only to maintain their own health but also to prevent transmission of the virus. The sudden disruption raised alarm among healthcare providers, patient advocates, and public health organizations.
“For ten weeks, 12,000 Floridians living with HIV faced uncertainty about whether they could fill their next prescription,” said Esteban Wood, Director of Advocacy and Legislative Affairs at the AIDS Healthcare Foundation (AHF). “This legislation ensures they can now access the medications they need.”
Key Provisions of the Legislation
The emergency legislation addresses both the immediate funding shortfall and the broader structural concerns surrounding ADAP. Its main provisions include:
- Emergency Funding Allocation: The law appropriates $30.9 million to sustain the program through June 30, 2026. This “bridge funding” is intended to prevent interruptions in care while longer-term solutions are developed.
- Restoration of Eligibility Criteria: ADAP eligibility has been restored to 400 percent of the Federal Poverty Level, allowing a significantly larger number of individuals to qualify for assistance.
- Medication Access: The program will resume providing medications directly to eligible individuals, ensuring continuity of treatment.
- Enhanced Financial Oversight: Beginning April 1, the Florida Department of Health must submit comprehensive monthly financial reports. These reports will be reviewed by the Governor’s Office of Policy and Budget, the Senate Appropriations Committee, and the House Budget Committee.
The reporting requirements mark a notable shift toward increased transparency. The Department of Health will be required to detail federal revenues and expenditures, including manufacturer rebates, as well as provide data on program enrollment, insurance status, prescription utilization by drug class, and any anticipated funding gaps. This level of financial scrutiny is unprecedented for the program and is intended to prevent similar crises in the future.
Impact on Patients and Communities
The legislation brings immediate relief to thousands of Floridians who rely on ADAP for life-saving medications. For individuals living with HIV, consistent access to antiretroviral therapy is critical. Interruptions in treatment can lead to viral rebound, increased risk of transmission, and long-term health complications.
Patient advocates have emphasized that the emotional and psychological toll of the disruption was significant. Many individuals were left uncertain about their health and financial stability, as they scrambled to find alternative sources of medication or feared going without treatment altogether.
“With this action, thousands of people can finally breathe a little easier,” Wood noted. “It restores not just access to medication, but also a sense of stability and dignity.”
Healthcare providers across the state have also welcomed the move, highlighting the importance of maintaining uninterrupted care. Clinics and support organizations had reported increased anxiety among patients and a surge in emergency requests for assistance during the period of reduced coverage.
Looking Ahead: Long-Term Sustainability
While the emergency legislation provides critical short-term relief, it is not a permanent solution. The funding and eligibility provisions are set to expire on June 30, 2026. The long-term structure and sustainability of Florida’s ADAP will be determined as part of the state’s Fiscal Year 2026–2027 budget process.
Advocacy groups, including the AIDS Healthcare Foundation, have expressed their commitment to working with state lawmakers to develop a more stable and resilient framework for the program. Ensuring consistent funding, maintaining broad eligibility, and improving administrative transparency will be key priorities in the months ahead.
The introduction of mandatory financial reporting is expected to play a central role in shaping future policy decisions. By providing lawmakers with detailed insights into program operations and funding flows, the new requirements aim to support more informed budgeting and oversight.
About AIDS Healthcare Foundation
The AIDS Healthcare Foundation (AHF) is the world’s largest nonprofit provider of HIV/AIDS medical care and advocacy services. The organization serves more than 2.8 million individuals across 50 countries, including the United States, nations in Africa, Latin America and the Caribbean, the Asia-Pacific region, and Eastern Europe.
AHF is known for its comprehensive approach, combining cutting-edge medical treatment with advocacy, testing, and prevention initiatives. In January 2025, the organization received the MLK Jr. Social Justice Award from The King Center, recognizing its leadership in advancing health equity and social justice.
The signing of this emergency legislation marks a significant step in addressing a critical healthcare disruption in Florida. By restoring funding, eligibility, and access to essential medications, state leaders have acted swiftly to protect vulnerable populations and stabilize a vital public health program.
However, the situation also underscores the importance of sustainable policy planning and robust oversight. As Florida moves toward its next budget cycle, the focus will remain on ensuring that ADAP can continue to meet the needs of those who depend on it—without interruption or uncertainty.
For now, thousands of Floridians living with HIV can regain access to the care they need, offering a renewed sense of security and hope for the future.
